Georgia L. Erbez's most recent trade in Coherus Biosciences Inc was a trade of 112,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Coherus Biosciences Inc | Georgia L. Erbez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 112,000 | 112,000 | - | - | Stock Option (Right to Buy) | |
| Codexis Inc. | Georgia L. Erbez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 161,250 | 161,250 | - | - | Stock Option (Right to Buy) | |
| Codexis Inc. | Georgia L. Erbez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 26,875 | 76,875 (0%) | 0% | 0 | Common Stock | |
| Codexis Inc. | Georgia L. Erbez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2024 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Codexis Inc. | Georgia L. Erbez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2024 | 50,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
| Coherus Biosciences Inc | Georgia L. Erbez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 114,000 | 114,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Georgia L. Erbez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 54,000 | 54,000 | - | - | Stock Option (Right to Buy) | |
| Harpoon Therapeutics Inc | Georgia L. Erbez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 115,000 | 115,000 | - | - | Employee Stock Option (right to buy) | |
| Harpoon Therapeutics Inc | Georgia L. Erbez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 115,000 | 115,000 | - | - | Employee Stock Option (right to buy) | |
| Harpoon Therapeutics Inc | Georgia L. Erbez | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 8.10 per share. | 22 Sep 2021 | 10,300 | 19,215 (0%) | 0% | 8.1 | 83,430 | Common Stock |
| Harpoon Therapeutics Inc | Georgia L. Erbez | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2021 | 25,000 | 145,908 | - | - | Employee Stock Option (right to buy) | |
| Harpoon Therapeutics Inc | Georgia L. Erbez | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.12 per share. | 17 Feb 2021 | 25,000 | 72,292 (0%) | 0% | 2.1 | 53,000 | Common Stock |
| Harpoon Therapeutics Inc | Georgia L. Erbez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 72,000 | 72,000 | - | - | Employee Stock Option (right to buy) | |
| Harpoon Therapeutics Inc | Georgia L. Erbez | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 11.40 per share. | 18 Aug 2020 | 5,000 | 8,915 (0%) | 0% | 11.4 | 57,000 | Common Stock |
| Harpoon Therapeutics Inc | Georgia L. Erbez | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 11.60 per share. | 18 Aug 2020 | 2,098 | 3,915 (0%) | 0% | 11.6 | 24,337 | Common Stock |
| Harpoon Therapeutics Inc | Georgia L. Erbez | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 10.92 per share. | 31 Jul 2020 | 1,817 | 1,817 (0%) | 0% | 10.9 | 19,842 | Common Stock |